Literature DB >> 16253640

Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high triglycerides: different pathophysiologic subsets in preeclampsia.

Elisa Llurba1, Elena Casals, Carmen Domínguez, Julián Delgado, Inmaculada Mercadé, Fátima Crispi, Pilar Martín-Gallán, Lluis Cabero, Eduard Gratacós.   

Abstract

Abnormal lipid metabolism has been proposed as a pathogenic factor of preeclampsia, although whether it is a constant feature in all preeclamptic patients is unclear. We assessed whether plasma triglyceride (TG) levels can distinguish a subgroup of preeclamptic women with alterations in lipoprotein profile from those with normal lipid metabolism and can be used to identify 2 distinct pathogenic groups in preeclampsia. This prospective study included 34 women with preeclampsia and 23 healthy pregnant women. Preeclamptic women were further subclassified into normal-TG (<250 mg/dL) and high-TG (>or=250 mg/dL) groups on the basis of the 90th percentile in our population. Low-density lipoproteins (LDLs) were ultracentrifuged and were separated into 4 subfractions, and lipid distribution in the subfractions was analyzed in all study groups. Vascular cell adhesion molecule-1 was also measured as a marker of endothelial dysfunction. Sixteen women with preeclampsia had high TGs (47% vs 13% in control subjects, P<.001). This subgroup showed a significant shift in lipid distribution, mainly, TGs, toward the small, dense LDL subfractions. However, preeclamptic patients in the normal-TG subgroup showed LDL subfraction lipid distribution similar to that of healthy pregnancies. Vascular cell adhesion molecule-1 levels were significantly elevated in preeclamptic patients in comparison with those in control subjects regardless of TG levels. The presence of a proatherogenic lipoprotein profile, previously described in preeclampsia, is characterized by increased small dense LDL and is exclusive to a subset of preeclamptic patients with high TG levels. These findings support the concept of heterogeneous pathogenic lines in preeclampsia and the use of subclassifications in pathophysiologic research on this condition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253640     DOI: 10.1016/j.metabol.2005.05.017

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study.

Authors:  Arpita Basu; Petar Alaupovic; Mingyuan Wu; Alicia J Jenkins; Yongxin Yu; Alison J Nankervis; Kristian F Hanssen; Hanne Scholz; Tore Henriksen; Bjørg Lorentzen; Torun Clausen; Satish K Garg; M Kathryn Menard; Samar M Hammad; James A Scardo; John R Stanley; Azar Dashti; Christopher E Aston; Timothy J Lyons
Journal:  J Clin Endocrinol Metab       Date:  2012-03-21       Impact factor: 5.958

2.  Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach.

Authors:  Che-Jung Chang; Dana Boyd Barr; P Barry Ryan; Parinya Panuwet; Melissa M Smarr; Ken Liu; Kurunthachalam Kannan; Volha Yakimavets; Youran Tan; ViLinh Ly; Carmen J Marsit; Dean P Jones; Elizabeth J Corwin; Anne L Dunlop; Donghai Liang
Journal:  Environ Int       Date:  2021-11-01       Impact factor: 9.621

Review 3.  Maternal metabolism and obesity: modifiable determinants of pregnancy outcome.

Authors:  Scott M Nelson; Phillippa Matthews; Lucilla Poston
Journal:  Hum Reprod Update       Date:  2009-12-04       Impact factor: 15.610

4.  Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study.

Authors:  Arnon Wiznitzer; Amit Mayer; Victor Novack; Eyal Sheiner; Harel Gilutz; Atul Malhotra; Lena Novack
Journal:  Am J Obstet Gynecol       Date:  2009-07-24       Impact factor: 8.661

5.  Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.

Authors:  Anne P Starling; Stephanie M Engel; Kristina W Whitworth; David B Richardson; Alison M Stuebe; Julie L Daniels; Line Småstuen Haug; Merete Eggesbø; Georg Becher; Azemira Sabaredzovic; Cathrine Thomsen; Ralph E Wilson; Gregory S Travlos; Jane A Hoppin; Donna D Baird; Matthew P Longnecker
Journal:  Environ Int       Date:  2013-11-02       Impact factor: 9.621

6.  Nutrients utilization in obese individuals with and without hypertriglyceridemia.

Authors:  Tiziana Montalcini; Theodora Lamprinoudi; Attilio Morrone; Elisa Mazza; Carmine Gazzaruso; Stefano Romeo; Arturo Pujia
Journal:  Nutrients       Date:  2014-02-21       Impact factor: 5.717

7.  Changes in oxidant-antioxidant status in young diabetic patients from clinical onset onwards.

Authors:  P Martín-Gallán; A Carrascosa; M Gussinyé; C Domínguez
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

8.  Why does a high-fat diet induce preeclampsia-like symptoms in pregnant rats.

Authors:  Jing Ge; Jun Wang; Dan Xue; Zhengsheng Zhu; Zhenyu Chen; Xiaoqiu Li; Dongfeng Su; Juan Du
Journal:  Neural Regen Res       Date:  2013-07-15       Impact factor: 5.135

9.  Prognostic Value of Cardiovascular Disease Risk Factors Measured in the First-Trimester on the Severity of Preeclampsia.

Authors:  Po-Jen Cheng; Shang-Yu Huang; Sheng-Yuan Su; Ching-Hwa Hsiao; Hsiu-Huei Peng; Tao Duan
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

10.  The effect of atorvastatin treatment duration on oxidative stress markers and lipid profile in patients with coronary artery diseases: A case series study.

Authors:  Gholamreza Shahsavari; Amir Raoufi; Aram Toolabi; Nahid Hosseninejadmir; Hassan Ahmadvand; Mehdi Safariebrahimsarabie
Journal:  ARYA Atheroscler       Date:  2017-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.